| Product Code: ETC9946072 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Herpes Zoster Drug Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Herpes Zoster Drug Market - Industry Life Cycle |
3.4 United Kingdom (UK) Herpes Zoster Drug Market - Porter's Five Forces |
3.5 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.6 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume Share, By Vaccine, 2021 & 2031F |
3.7 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United Kingdom (UK) Herpes Zoster Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of herpes zoster in the UK |
4.2.2 Growing awareness about the importance of early treatment for herpes zoster |
4.2.3 Advancements in medical technology leading to the development of more effective herpes zoster drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in the UK |
4.3.2 High competition among pharmaceutical companies offering herpes zoster drugs |
4.3.3 Limited reimbursement policies for herpes zoster drugs in the UK |
5 United Kingdom (UK) Herpes Zoster Drug Market Trends |
6 United Kingdom (UK) Herpes Zoster Drug Market, By Types |
6.1 United Kingdom (UK) Herpes Zoster Drug Market, By Drug |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Drug, 2021- 2031F |
6.1.3 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Anti-Viral Agents, 2021- 2031F |
6.1.4 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Anti-Inflammatory Agents, 2021- 2031F |
6.1.5 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Analgesics, 2021- 2031F |
6.1.6 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Herpes Zoster Drug Market, By Vaccine |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Zostavax, 2021- 2031F |
6.2.3 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Shingrix, 2021- 2031F |
6.2.4 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Herpes Zoster Drug Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.5 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Herpes Zoster Drug Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.3 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Direct Tenders, 2021- 2031F |
6.5 United Kingdom (UK) Herpes Zoster Drug Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 United Kingdom (UK) Herpes Zoster Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Herpes Zoster Drug Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Herpes Zoster Drug Market Export to Major Countries |
7.2 United Kingdom (UK) Herpes Zoster Drug Market Imports from Major Countries |
8 United Kingdom (UK) Herpes Zoster Drug Market Key Performance Indicators |
8.1 Number of prescriptions filled for herpes zoster drugs |
8.2 Patient adherence rate to prescribed herpes zoster drug regimens |
8.3 Rate of adverse events reported for herpes zoster drugs |
9 United Kingdom (UK) Herpes Zoster Drug Market - Opportunity Assessment |
9.1 United Kingdom (UK) Herpes Zoster Drug Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.2 United Kingdom (UK) Herpes Zoster Drug Market Opportunity Assessment, By Vaccine, 2021 & 2031F |
9.3 United Kingdom (UK) Herpes Zoster Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United Kingdom (UK) Herpes Zoster Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 United Kingdom (UK) Herpes Zoster Drug Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United Kingdom (UK) Herpes Zoster Drug Market - Competitive Landscape |
10.1 United Kingdom (UK) Herpes Zoster Drug Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Herpes Zoster Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here